

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 9.19665868 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 9.19665868 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.52137505 |
| 4 | COPII vesicle coating (GO:0048208) | 6.05127401 |
| 5 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.89809142 |
| 6 | positive regulation of nuclease activity (GO:0032075) | 5.73149120 |
| 7 | protein retention in ER lumen (GO:0006621) | 5.67333643 |
| 8 | regulation of nuclease activity (GO:0032069) | 5.28733783 |
| 9 | protein maturation by protein folding (GO:0022417) | 5.13160388 |
| 10 | endoplasmic reticulum unfolded protein response (GO:0030968) | 5.11460385 |
| 11 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.01365265 |
| 12 | cellular response to unfolded protein (GO:0034620) | 4.97234005 |
| 13 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.87417021 |
| 14 | ER-nucleus signaling pathway (GO:0006984) | 4.78466019 |
| 15 | cellular response to topologically incorrect protein (GO:0035967) | 4.76491422 |
| 16 | sequestering of metal ion (GO:0051238) | 4.64088024 |
| 17 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.56594452 |
| 18 | signal peptide processing (GO:0006465) | 4.37270723 |
| 19 | 4-hydroxyproline metabolic process (GO:0019471) | 4.35779517 |
| 20 | exocrine pancreas development (GO:0031017) | 4.30046527 |
| 21 | response to endoplasmic reticulum stress (GO:0034976) | 4.12663044 |
| 22 | vesicle coating (GO:0006901) | 4.03528836 |
| 23 | protein localization to endosome (GO:0036010) | 3.99625917 |
| 24 | response to unfolded protein (GO:0006986) | 3.93655999 |
| 25 | response to topologically incorrect protein (GO:0035966) | 3.82470179 |
| 26 | peptidyl-asparagine modification (GO:0018196) | 3.76183683 |
| 27 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.76065260 |
| 28 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.72764287 |
| 29 | tetrahydrofolate metabolic process (GO:0046653) | 3.71045164 |
| 30 | endocrine pancreas development (GO:0031018) | 3.65005276 |
| 31 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.63353404 |
| 32 | intestinal cholesterol absorption (GO:0030299) | 3.54830596 |
| 33 | ER overload response (GO:0006983) | 3.54238421 |
| 34 | skin morphogenesis (GO:0043589) | 3.51847435 |
| 35 | valine metabolic process (GO:0006573) | 3.45947817 |
| 36 | protein N-linked glycosylation (GO:0006487) | 3.38617617 |
| 37 | regulation of early endosome to late endosome transport (GO:2000641) | 3.32248918 |
| 38 | peptide hormone processing (GO:0016486) | 3.29651330 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 3.28523083 |
| 40 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.28050867 |
| 41 | regulation of extracellular matrix disassembly (GO:0010715) | 3.26988434 |
| 42 | hypotonic response (GO:0006971) | 3.22560611 |
| 43 | regulation of hexokinase activity (GO:1903299) | 3.19590636 |
| 44 | regulation of glucokinase activity (GO:0033131) | 3.19590636 |
| 45 | barbed-end actin filament capping (GO:0051016) | 3.18249494 |
| 46 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.16484960 |
| 47 | cysteine metabolic process (GO:0006534) | 3.12731902 |
| 48 | positive regulation of extracellular matrix organization (GO:1903055) | 3.11975396 |
| 49 | desmosome organization (GO:0002934) | 3.10567769 |
| 50 | cell adhesion mediated by integrin (GO:0033627) | 3.10007017 |
| 51 | stress fiber assembly (GO:0043149) | 3.08863943 |
| 52 | intestinal epithelial cell development (GO:0060576) | 3.07510046 |
| 53 | one-carbon metabolic process (GO:0006730) | 3.06212156 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05580118 |
| 55 | negative regulation of anoikis (GO:2000811) | 3.03484364 |
| 56 | type B pancreatic cell development (GO:0003323) | 3.02514926 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.02210802 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 3.02210802 |
| 59 | surfactant homeostasis (GO:0043129) | 2.95980147 |
| 60 | peptide catabolic process (GO:0043171) | 2.95963900 |
| 61 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.95952582 |
| 62 | Golgi organization (GO:0007030) | 2.95610798 |
| 63 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.94653256 |
| 64 | protein carboxylation (GO:0018214) | 2.94653256 |
| 65 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.93781520 |
| 66 | embryonic process involved in female pregnancy (GO:0060136) | 2.91380482 |
| 67 | L-phenylalanine metabolic process (GO:0006558) | 2.88526007 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.88526007 |
| 69 | cell-substrate junction assembly (GO:0007044) | 2.84915503 |
| 70 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.83794409 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.83794409 |
| 72 | proline biosynthetic process (GO:0006561) | 2.82636196 |
| 73 | negative regulation of fatty acid transport (GO:2000192) | 2.81555971 |
| 74 | folic acid-containing compound metabolic process (GO:0006760) | 2.80999992 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 2.80077646 |
| 76 | cell redox homeostasis (GO:0045454) | 2.78468339 |
| 77 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.78044820 |
| 78 | basement membrane organization (GO:0071711) | 2.77620875 |
| 79 | protein autoprocessing (GO:0016540) | 2.75217763 |
| 80 | response to laminar fluid shear stress (GO:0034616) | 2.73814169 |
| 81 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.73566358 |
| 82 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.73566358 |
| 83 | homocysteine metabolic process (GO:0050667) | 2.72893151 |
| 84 | transcytosis (GO:0045056) | 2.72470170 |
| 85 | regulation of anoikis (GO:2000209) | 2.71382800 |
| 86 | hormone catabolic process (GO:0042447) | 2.71270295 |
| 87 | positive regulation of receptor recycling (GO:0001921) | 2.71035719 |
| 88 | intestinal absorption (GO:0050892) | 2.71020655 |
| 89 | endodermal cell differentiation (GO:0035987) | 2.68750979 |
| 90 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.66355391 |
| 91 | glandular epithelial cell development (GO:0002068) | 2.66074012 |
| 92 | IMP biosynthetic process (GO:0006188) | 2.65446253 |
| 93 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.64867786 |
| 94 | lysine metabolic process (GO:0006553) | 2.64091093 |
| 95 | lysine catabolic process (GO:0006554) | 2.64091093 |
| 96 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.63533779 |
| 97 | regulation of translational fidelity (GO:0006450) | 2.63415775 |
| 98 | glandular epithelial cell differentiation (GO:0002067) | 2.62714413 |
| 99 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.61997980 |
| 100 | cellular zinc ion homeostasis (GO:0006882) | 2.61555128 |
| 101 | epithelial cell-cell adhesion (GO:0090136) | 2.61430411 |
| 102 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.60936931 |
| 103 | glycine metabolic process (GO:0006544) | 2.59839043 |
| 104 | regulation of plasminogen activation (GO:0010755) | 2.59817914 |
| 105 | pinocytosis (GO:0006907) | 2.58824508 |
| 106 | cell migration involved in heart development (GO:0060973) | 2.58496151 |
| 107 | protein hydroxylation (GO:0018126) | 2.57838548 |
| 108 | nuclear pore complex assembly (GO:0051292) | 2.57080877 |
| 109 | focal adhesion assembly (GO:0048041) | 2.56986225 |
| 110 | cell-substrate adherens junction assembly (GO:0007045) | 2.56986225 |
| 111 | negative regulation of fibrinolysis (GO:0051918) | 2.56059223 |
| 112 | regulation of extracellular matrix organization (GO:1903053) | 2.56039511 |
| 113 | maternal placenta development (GO:0001893) | 2.55747668 |
| 114 | tricarboxylic acid metabolic process (GO:0072350) | 2.55528810 |
| 115 | mannose metabolic process (GO:0006013) | 2.55212994 |
| 116 | adherens junction assembly (GO:0034333) | 2.54472857 |
| 117 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.53883557 |
| 118 | hemidesmosome assembly (GO:0031581) | 2.52361128 |
| 119 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.51102056 |
| 120 | response to thyroid hormone (GO:0097066) | 2.50779884 |
| 121 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.49415648 |
| 122 | cellular modified amino acid catabolic process (GO:0042219) | 2.48647716 |
| 123 | adhesion of symbiont to host (GO:0044406) | 2.48200514 |
| 124 | cortical actin cytoskeleton organization (GO:0030866) | 2.47635715 |
| 125 | positive regulation of histone deacetylation (GO:0031065) | 2.45755689 |
| 126 | nuclear pore organization (GO:0006999) | 2.44149454 |
| 127 | maintenance of protein localization in organelle (GO:0072595) | 2.43545745 |
| 128 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.43484758 |
| 129 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.43460125 |
| 130 | macroautophagy (GO:0016236) | 2.42940631 |
| 131 | positive regulation of osteoblast proliferation (GO:0033690) | 2.41886968 |
| 132 | adhesion of symbiont to host cell (GO:0044650) | 2.40325153 |
| 133 | virion attachment to host cell (GO:0019062) | 2.40325153 |
| 134 | collagen fibril organization (GO:0030199) | 2.40222964 |
| 135 | pteridine-containing compound metabolic process (GO:0042558) | 2.38236813 |
| 136 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.37345397 |
| 137 | hyaluronan catabolic process (GO:0030214) | 2.36948280 |
| 138 | ethanol oxidation (GO:0006069) | 2.36534943 |
| 139 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.36122094 |
| 140 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.35814315 |
| 141 | regulation of fibrinolysis (GO:0051917) | 2.35399460 |
| 142 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.34817337 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.34620400 |
| 144 | folic acid metabolic process (GO:0046655) | 2.34477125 |
| 145 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.34409759 |
| 146 | apoptotic cell clearance (GO:0043277) | 2.34345192 |
| 147 | chondrocyte development (GO:0002063) | 2.32954120 |
| 148 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.32864964 |
| 149 | activation of Rac GTPase activity (GO:0032863) | 2.32630375 |
| 150 | cellular response to glucose starvation (GO:0042149) | 2.31404647 |
| 151 | alpha-linolenic acid metabolic process (GO:0036109) | 2.31387537 |
| 152 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.30435665 |
| 153 | chondrocyte proliferation (GO:0035988) | 2.29126335 |
| 154 | aromatic amino acid family catabolic process (GO:0009074) | 2.29117638 |
| 155 | negative regulation of cell size (GO:0045792) | 2.28658548 |
| 156 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.27989088 |
| 157 | complement activation, alternative pathway (GO:0006957) | 2.27920160 |
| 158 | high-density lipoprotein particle remodeling (GO:0034375) | 2.27848572 |
| 159 | oxaloacetate metabolic process (GO:0006107) | 2.27745488 |
| 160 | peptidyl-proline hydroxylation (GO:0019511) | 2.26504248 |
| 161 | membrane protein ectodomain proteolysis (GO:0006509) | 2.26068342 |
| 162 | membrane raft organization (GO:0031579) | 2.25557314 |
| 163 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.24349571 |
| 164 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.23453042 |
| 165 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.22213571 |
| 166 | collagen metabolic process (GO:0032963) | 2.19120089 |
| 167 | cortical cytoskeleton organization (GO:0030865) | 2.17752968 |
| 168 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.16858632 |
| 169 | iron ion import (GO:0097286) | 2.16665100 |
| 170 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.15952413 |
| 171 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.14371049 |
| 172 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.13380965 |
| 173 | fibril organization (GO:0097435) | 2.12190165 |
| 174 | regulation of protein localization to plasma membrane (GO:1903076) | 2.10474655 |
| 175 | viral entry into host cell (GO:0046718) | 2.10039207 |
| 176 | regulation of apoptotic cell clearance (GO:2000425) | 2.09651598 |
| 177 | cell volume homeostasis (GO:0006884) | 2.09206846 |
| 178 | extracellular matrix disassembly (GO:0022617) | 2.08974534 |
| 179 | modulation by symbiont of host cellular process (GO:0044068) | 2.08541739 |
| 180 | endocytic recycling (GO:0032456) | 2.07716377 |
| 181 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.07656920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.44380573 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.31021633 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.00039060 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.88328879 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.19652965 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09079041 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.05202128 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.73094521 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.65501151 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52510013 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.40283266 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32282060 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.31852483 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.30629600 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.28594661 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.28258894 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21158255 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.20518479 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15009588 |
| 20 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.08495738 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.08094978 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02698553 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.01536529 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99377320 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.93839819 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.89634506 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89345127 |
| 28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89224303 |
| 29 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.81893174 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.80126768 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.79592630 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75337051 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74863509 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72509075 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71917249 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71646998 |
| 37 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71253573 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.70355018 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.69307472 |
| 40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68164651 |
| 41 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.67607980 |
| 42 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.64890149 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.62225247 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61294182 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.57918866 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56630435 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55476309 |
| 48 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.51868388 |
| 49 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.50361762 |
| 50 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.50361762 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.49592399 |
| 52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.48552372 |
| 53 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.46555195 |
| 54 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.45672655 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45604602 |
| 56 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45109624 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42960034 |
| 58 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.42954920 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.42503490 |
| 60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42286170 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.41809357 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41444420 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40930344 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39676212 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38203774 |
| 66 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35871424 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35127326 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34247747 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33869651 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33576382 |
| 71 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.33140488 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33055340 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33048616 |
| 74 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.32709057 |
| 75 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.32709057 |
| 76 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31926210 |
| 77 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31796427 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31246097 |
| 79 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30740686 |
| 80 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.28843655 |
| 81 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.28381243 |
| 82 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.27835028 |
| 83 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.27666535 |
| 84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26579184 |
| 85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.25727891 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23797812 |
| 87 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.23457363 |
| 88 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23210267 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21715014 |
| 90 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21419785 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20355929 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19948843 |
| 93 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.19602423 |
| 94 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.19328997 |
| 95 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19219563 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18142731 |
| 97 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17199417 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17122848 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17103176 |
| 100 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16929609 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16531488 |
| 102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15821097 |
| 103 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15533709 |
| 104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15421010 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15295285 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14932650 |
| 107 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14508611 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14434544 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14371966 |
| 110 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14310483 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13311912 |
| 112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13193740 |
| 113 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11815720 |
| 114 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11765018 |
| 115 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.11171912 |
| 116 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.11026322 |
| 117 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.11004242 |
| 118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10423548 |
| 119 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10411888 |
| 120 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10041340 |
| 121 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09117671 |
| 122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08541450 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08413716 |
| 124 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08261095 |
| 125 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08190977 |
| 126 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07617661 |
| 127 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06604344 |
| 128 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06584936 |
| 129 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06094255 |
| 130 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06039858 |
| 131 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05927284 |
| 132 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05704571 |
| 133 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05304668 |
| 134 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04914449 |
| 135 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04759992 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04353737 |
| 137 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03322099 |
| 138 | MYB_26560356_Chip-Seq_TH1_Human | 1.00883711 |
| 139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99098094 |
| 140 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98210838 |
| 141 | MYB_26560356_Chip-Seq_TH2_Human | 0.97287665 |
| 142 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97286406 |
| 143 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.96954502 |
| 144 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96600896 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95876123 |
| 146 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95624572 |
| 147 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95595958 |
| 148 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95093077 |
| 149 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94985918 |
| 150 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94948052 |
| 151 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94524578 |
| 152 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94521361 |
| 153 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94500222 |
| 154 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.94209974 |
| 155 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93851313 |
| 156 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92347196 |
| 157 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91961237 |
| 158 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91128185 |
| 159 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90551548 |
| 160 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89457982 |
| 161 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89249569 |
| 162 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.88558844 |
| 163 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87828020 |
| 164 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87431407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.48348725 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.43519941 |
| 3 | MP0005365_abnormal_bile_salt | 3.21758903 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 2.59754007 |
| 5 | MP0005220_abnormal_exocrine_pancreas | 2.53951429 |
| 6 | MP0005083_abnormal_biliary_tract | 2.52132026 |
| 7 | MP0002693_abnormal_pancreas_physiology | 2.46463451 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.45611515 |
| 9 | MP0005275_abnormal_skin_tensile | 2.38815537 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.33023385 |
| 11 | MP0001944_abnormal_pancreas_morphology | 2.25771187 |
| 12 | MP0001958_emphysema | 2.25483125 |
| 13 | MP0003091_abnormal_cell_migration | 2.22227633 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.19101693 |
| 15 | MP0003279_aneurysm | 2.09156705 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.08673360 |
| 17 | MP0005360_urolithiasis | 2.07159230 |
| 18 | MP0006054_spinal_hemorrhage | 2.02023190 |
| 19 | MP0005409_darkened_coat_color | 1.98370873 |
| 20 | MP0005076_abnormal_cell_differentiation | 1.97936667 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.93561924 |
| 22 | MP0004043_abnormal_pH_regulation | 1.93507479 |
| 23 | MP0003283_abnormal_digestive_organ | 1.92153540 |
| 24 | MP0005503_abnormal_tendon_morphology | 1.89726457 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.87693952 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.82695810 |
| 27 | MP0003252_abnormal_bile_duct | 1.80450504 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77310726 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.70391481 |
| 30 | MP0003195_calcinosis | 1.70305619 |
| 31 | MP0003693_abnormal_embryo_hatching | 1.65186837 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.62284168 |
| 33 | MP0009840_abnormal_foam_cell | 1.61377054 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.56266089 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.55752474 |
| 36 | MP0001849_ear_inflammation | 1.55643773 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.49304583 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.48976419 |
| 39 | MP0002078_abnormal_glucose_homeostasis | 1.46862997 |
| 40 | MP0000609_abnormal_liver_physiology | 1.46813092 |
| 41 | MP0003868_abnormal_feces_composition | 1.46419909 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.45541381 |
| 43 | MP0005408_hypopigmentation | 1.43120915 |
| 44 | MP0003303_peritoneal_inflammation | 1.42769498 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.37200402 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.36105080 |
| 47 | MP0000767_abnormal_smooth_muscle | 1.34770980 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.34518048 |
| 49 | MP0004957_abnormal_blastocyst_morpholog | 1.30502127 |
| 50 | MP0005379_endocrine/exocrine_gland_phen | 1.23577092 |
| 51 | MP0003186_abnormal_redox_activity | 1.22383350 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.21795684 |
| 53 | MP0001915_intracranial_hemorrhage | 1.20836718 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.19232161 |
| 55 | MP0003436_decreased_susceptibility_to | 1.18118205 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.17228022 |
| 57 | MP0005451_abnormal_body_composition | 1.16507306 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.15615434 |
| 59 | MP0008260_abnormal_autophagy | 1.14500916 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.14435376 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.13643643 |
| 62 | MP0008004_abnormal_stomach_pH | 1.13448449 |
| 63 | MP0004858_abnormal_nervous_system | 1.09971363 |
| 64 | MP0005332_abnormal_amino_acid | 1.09383866 |
| 65 | MP0000598_abnormal_liver_morphology | 1.08300396 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.08002775 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.07635859 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 1.05839038 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 1.05528833 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.05383415 |
| 71 | MP0000678_abnormal_parathyroid_gland | 1.05379985 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 1.04629322 |
| 73 | MP0001851_eye_inflammation | 1.04627453 |
| 74 | MP0001756_abnormal_urination | 1.03640527 |
| 75 | MP0000613_abnormal_salivary_gland | 1.02507704 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.02193238 |
| 77 | MP0003329_amyloid_beta_deposits | 1.00454399 |
| 78 | MP0010307_abnormal_tumor_latency | 1.00039161 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.99255152 |
| 80 | MP0009672_abnormal_birth_weight | 0.99216976 |
| 81 | MP0005164_abnormal_response_to | 0.96937880 |
| 82 | MP0002796_impaired_skin_barrier | 0.96784872 |
| 83 | MP0000858_altered_metastatic_potential | 0.95413536 |
| 84 | MP0003448_altered_tumor_morphology | 0.95035315 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 0.93650438 |
| 86 | MP0005165_increased_susceptibility_to | 0.92447898 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.92435505 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 0.91805035 |
| 89 | MP0004233_abnormal_muscle_weight | 0.91558791 |
| 90 | MP0001879_abnormal_lymphatic_vessel | 0.89938048 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 0.88410783 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.88350519 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.87439003 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.86939656 |
| 95 | MP0005023_abnormal_wound_healing | 0.86228607 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 0.85969620 |
| 97 | MP0001730_embryonic_growth_arrest | 0.84651001 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.83997090 |
| 99 | MP0000604_amyloidosis | 0.83914025 |
| 100 | MP0001661_extended_life_span | 0.82724635 |
| 101 | MP0003959_abnormal_lean_body | 0.81442125 |
| 102 | MP0002009_preneoplasia | 0.81351014 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.81295312 |
| 104 | MP0003984_embryonic_growth_retardation | 0.80578395 |
| 105 | MP0004947_skin_inflammation | 0.80471583 |
| 106 | MP0002086_abnormal_extraembryonic_tissu | 0.80264868 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.80102828 |
| 108 | MP0002088_abnormal_embryonic_growth/wei | 0.80036922 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.79891836 |
| 110 | MP0000733_abnormal_muscle_development | 0.79692309 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.79389782 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.79350912 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.79053093 |
| 114 | MP0003828_pulmonary_edema | 0.79025378 |
| 115 | MP0004197_abnormal_fetal_growth/weight/ | 0.78788418 |
| 116 | MP0006138_congestive_heart_failure | 0.77346630 |
| 117 | MP0005257_abnormal_intraocular_pressure | 0.77127257 |
| 118 | MP0000462_abnormal_digestive_system | 0.76876015 |
| 119 | MP0005310_abnormal_salivary_gland | 0.76839472 |
| 120 | MP0003795_abnormal_bone_structure | 0.76145330 |
| 121 | MP0001764_abnormal_homeostasis | 0.76132745 |
| 122 | MP0001542_abnormal_bone_strength | 0.76034270 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.75531101 |
| 124 | MP0001614_abnormal_blood_vessel | 0.74984675 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.74966214 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.73653499 |
| 127 | MP0002295_abnormal_pulmonary_circulatio | 0.73338062 |
| 128 | MP0008057_abnormal_DNA_replication | 0.72874070 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.72733558 |
| 130 | MP0005390_skeleton_phenotype | 0.71346088 |
| 131 | MP0005380_embryogenesis_phenotype | 0.70763504 |
| 132 | MP0001672_abnormal_embryogenesis/_devel | 0.70763504 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.70028503 |
| 134 | MP0003890_abnormal_embryonic-extraembry | 0.69998582 |
| 135 | MP0003075_altered_response_to | 0.69677970 |
| 136 | MP0003045_fibrosis | 0.69362603 |
| 137 | MP0002060_abnormal_skin_morphology | 0.68553215 |
| 138 | MP0002928_abnormal_bile_duct | 0.68522824 |
| 139 | MP0009278_abnormal_bone_marrow | 0.68085802 |
| 140 | MP0009642_abnormal_blood_homeostasis | 0.67885924 |
| 141 | MP0002080_prenatal_lethality | 0.67552335 |
| 142 | MP0008469_abnormal_protein_level | 0.67349078 |
| 143 | MP0000350_abnormal_cell_proliferation | 0.66637912 |
| 144 | MP0003953_abnormal_hormone_level | 0.66589843 |
| 145 | MP0000627_abnormal_mammary_gland | 0.65622398 |
| 146 | MP0005388_respiratory_system_phenotype | 0.65519152 |
| 147 | MP0002133_abnormal_respiratory_system | 0.65519152 |
| 148 | MP0000249_abnormal_blood_vessel | 0.64820902 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.64774788 |
| 150 | MP0002128_abnormal_blood_circulation | 0.64706566 |
| 151 | MP0001697_abnormal_embryo_size | 0.64347703 |
| 152 | MP0005621_abnormal_cell_physiology | 0.64180140 |
| 153 | MP0001533_abnormal_skeleton_physiology | 0.63450206 |
| 154 | MP0003656_abnormal_erythrocyte_physiolo | 0.63413107 |
| 155 | MP0009703_decreased_birth_body | 0.63348821 |
| 156 | MP0002269_muscular_atrophy | 0.62896432 |
| 157 | MP0000003_abnormal_adipose_tissue | 0.62894918 |
| 158 | MP0001243_abnormal_dermal_layer | 0.62830134 |
| 159 | MP0001881_abnormal_mammary_gland | 0.61327114 |
| 160 | MP0000358_abnormal_cell_content/ | 0.61318913 |
| 161 | MP0003077_abnormal_cell_cycle | 0.60401378 |
| 162 | MP0004272_abnormal_basement_membrane | 0.59875004 |
| 163 | MP0003119_abnormal_digestive_system | 0.58532601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.49860613 |
| 2 | Hypoglycemic seizures (HP:0002173) | 5.32863289 |
| 3 | Hypoglycemic coma (HP:0001325) | 5.30588662 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.69605574 |
| 5 | Premature rupture of membranes (HP:0001788) | 4.43569604 |
| 6 | Abnormality of the intrinsic pathway (HP:0010989) | 4.42036298 |
| 7 | Symptomatic seizures (HP:0011145) | 4.16211083 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90724713 |
| 9 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.78564348 |
| 10 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.78564348 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 3.68947962 |
| 12 | Hyperglycemia (HP:0003074) | 3.64989616 |
| 13 | Vascular tortuosity (HP:0004948) | 3.58943011 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.58856784 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.51486792 |
| 16 | Late onset (HP:0003584) | 3.49227996 |
| 17 | Arterial tortuosity (HP:0005116) | 3.44736524 |
| 18 | Mucopolysacchariduria (HP:0008155) | 3.43886426 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.43886426 |
| 20 | Vertebral compression fractures (HP:0002953) | 3.39754041 |
| 21 | Ketoacidosis (HP:0001993) | 3.34157742 |
| 22 | Aortic dissection (HP:0002647) | 3.15334341 |
| 23 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.15230904 |
| 24 | Aortic aneurysm (HP:0004942) | 3.05363747 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.01470625 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.99701029 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.99701029 |
| 28 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.98905064 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.96867725 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.96867725 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.96867725 |
| 32 | Deep venous thrombosis (HP:0002625) | 2.95646357 |
| 33 | Flat acetabular roof (HP:0003180) | 2.84567526 |
| 34 | Ketosis (HP:0001946) | 2.82339759 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.79814441 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 2.76599847 |
| 37 | Xanthomatosis (HP:0000991) | 2.75775813 |
| 38 | Wormian bones (HP:0002645) | 2.74662373 |
| 39 | Dilatation of the ascending aorta (HP:0005111) | 2.69753026 |
| 40 | Fat malabsorption (HP:0002630) | 2.60528688 |
| 41 | Bladder diverticulum (HP:0000015) | 2.57016385 |
| 42 | Insulin resistance (HP:0000855) | 2.54334836 |
| 43 | Atrophic scars (HP:0001075) | 2.53736214 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.48460125 |
| 45 | Prolonged partial thromboplastin time (HP:0003645) | 2.46050775 |
| 46 | Gout (HP:0001997) | 2.45059818 |
| 47 | Fragile skin (HP:0001030) | 2.43789200 |
| 48 | Abnormality of the anterior horn cell (HP:0006802) | 2.43535114 |
| 49 | Degeneration of anterior horn cells (HP:0002398) | 2.43535114 |
| 50 | Skin nodule (HP:0200036) | 2.43225980 |
| 51 | Ankle contracture (HP:0006466) | 2.42082491 |
| 52 | Mitral valve prolapse (HP:0001634) | 2.38985720 |
| 53 | Blue sclerae (HP:0000592) | 2.36531142 |
| 54 | Hyperacusis (HP:0010780) | 2.36201846 |
| 55 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.35087695 |
| 56 | Peritonitis (HP:0002586) | 2.34824353 |
| 57 | Biconcave vertebral bodies (HP:0004586) | 2.34505575 |
| 58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.31658743 |
| 59 | Hypobetalipoproteinemia (HP:0003563) | 2.31597193 |
| 60 | Back pain (HP:0003418) | 2.31586114 |
| 61 | Acute hepatic failure (HP:0006554) | 2.29814933 |
| 62 | Spondylolisthesis (HP:0003302) | 2.29730171 |
| 63 | Short nail (HP:0001799) | 2.20289030 |
| 64 | Thrombocytosis (HP:0001894) | 2.19021098 |
| 65 | Cervical subluxation (HP:0003308) | 2.18685057 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.18502776 |
| 67 | Broad face (HP:0000283) | 2.17774104 |
| 68 | Ankyloglossia (HP:0010296) | 2.17182630 |
| 69 | Hand muscle atrophy (HP:0009130) | 2.16509894 |
| 70 | Mitral stenosis (HP:0001718) | 2.16336332 |
| 71 | Pancreatitis (HP:0001733) | 2.15850692 |
| 72 | Thin bony cortex (HP:0002753) | 2.14186141 |
| 73 | Abnormality of the acetabulum (HP:0003170) | 2.14086703 |
| 74 | Abnormal biliary tract morphology (HP:0012440) | 2.12892255 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 2.11393740 |
| 76 | Neonatal short-limb short stature (HP:0008921) | 2.10902812 |
| 77 | Myocardial infarction (HP:0001658) | 2.09244010 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.08489062 |
| 79 | Shallow orbits (HP:0000586) | 2.07680117 |
| 80 | Limb hypertonia (HP:0002509) | 2.07181976 |
| 81 | Abnormality of carpal bone ossification (HP:0006257) | 2.06888822 |
| 82 | Asymmetry of the thorax (HP:0001555) | 2.06592852 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 2.05974783 |
| 84 | Mitral regurgitation (HP:0001653) | 2.04051096 |
| 85 | Prominent metopic ridge (HP:0005487) | 2.03852151 |
| 86 | Spontaneous hematomas (HP:0007420) | 2.03057672 |
| 87 | Broad metatarsal (HP:0001783) | 2.02791461 |
| 88 | Thoracolumbar scoliosis (HP:0002944) | 2.02476564 |
| 89 | Hyperextensible skin (HP:0000974) | 2.01848560 |
| 90 | Joint laxity (HP:0001388) | 2.00349342 |
| 91 | Abnormality of oral frenula (HP:0000190) | 1.99689671 |
| 92 | Soft skin (HP:0000977) | 1.99222585 |
| 93 | Abnormal pancreas size (HP:0012094) | 1.98863993 |
| 94 | Elevated alkaline phosphatase (HP:0003155) | 1.98081249 |
| 95 | Spinal rigidity (HP:0003306) | 1.97631464 |
| 96 | Complement deficiency (HP:0004431) | 1.96904761 |
| 97 | Disproportionate tall stature (HP:0001519) | 1.96567974 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 1.96440838 |
| 99 | Spinal cord lesions (HP:0100561) | 1.96288470 |
| 100 | Syringomyelia (HP:0003396) | 1.96288470 |
| 101 | Abnormal ossification of hand bones (HP:0005921) | 1.96240161 |
| 102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94262246 |
| 103 | Large for gestational age (HP:0001520) | 1.92987830 |
| 104 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91991054 |
| 105 | Arterial thrombosis (HP:0004420) | 1.90702140 |
| 106 | Genu recurvatum (HP:0002816) | 1.89961148 |
| 107 | Abdominal distention (HP:0003270) | 1.89925581 |
| 108 | Insomnia (HP:0100785) | 1.89523633 |
| 109 | Hyperbilirubinemia (HP:0002904) | 1.88994649 |
| 110 | Severe short stature (HP:0003510) | 1.87981702 |
| 111 | Steatorrhea (HP:0002570) | 1.87250206 |
| 112 | Polycythemia (HP:0001901) | 1.85916446 |
| 113 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85609408 |
| 114 | Abnormality of dentin (HP:0010299) | 1.85336355 |
| 115 | Exocrine pancreatic insufficiency (HP:0001738) | 1.84644501 |
| 116 | Eczematoid dermatitis (HP:0000976) | 1.83118366 |
| 117 | Vertebral arch anomaly (HP:0008438) | 1.81612887 |
| 118 | Aneurysm (HP:0002617) | 1.81125756 |
| 119 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.80918799 |
| 120 | Ulnar bowing (HP:0003031) | 1.80069299 |
| 121 | Increased connective tissue (HP:0009025) | 1.79927690 |
| 122 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.78121588 |
| 123 | Hypolipoproteinemia (HP:0010981) | 1.77610178 |
| 124 | Esophageal varix (HP:0002040) | 1.76476156 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 1.76366696 |
| 126 | Hyperglycinemia (HP:0002154) | 1.75138928 |
| 127 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74927277 |
| 128 | Cerebral inclusion bodies (HP:0100314) | 1.74869145 |
| 129 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74739788 |
| 130 | Cerebral aneurysm (HP:0004944) | 1.72829500 |
| 131 | Neurofibrillary tangles (HP:0002185) | 1.72484443 |
| 132 | Aortic regurgitation (HP:0001659) | 1.72476347 |
| 133 | Osteomalacia (HP:0002749) | 1.71608071 |
| 134 | Beaking of vertebral bodies (HP:0004568) | 1.71325915 |
| 135 | Thrombophlebitis (HP:0004418) | 1.71118438 |
| 136 | Progressive neurologic deterioration (HP:0002344) | 1.70452491 |
| 137 | Persistence of primary teeth (HP:0006335) | 1.69773487 |
| 138 | Abnormality of T cell physiology (HP:0011840) | 1.69660774 |
| 139 | Multiple enchondromatosis (HP:0005701) | 1.69381489 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.68691217 |
| 141 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.68392047 |
| 142 | Hyperparathyroidism (HP:0000843) | 1.68131492 |
| 143 | Upper limb amyotrophy (HP:0009129) | 1.67817535 |
| 144 | Distal upper limb amyotrophy (HP:0007149) | 1.67817535 |
| 145 | Abnormality of the metopic suture (HP:0005556) | 1.67810664 |
| 146 | Cellulitis (HP:0100658) | 1.66942203 |
| 147 | Abnormality of complement system (HP:0005339) | 1.66744157 |
| 148 | Hyperlipoproteinemia (HP:0010980) | 1.66424277 |
| 149 | Abnormal foot bone ossification (HP:0010675) | 1.66398544 |
| 150 | Biliary tract neoplasm (HP:0100574) | 1.66254868 |
| 151 | Coxa vara (HP:0002812) | 1.66188275 |
| 152 | Overgrowth (HP:0001548) | 1.66108250 |
| 153 | Bowel diverticulosis (HP:0005222) | 1.65908033 |
| 154 | Type I diabetes mellitus (HP:0100651) | 1.65404649 |
| 155 | Joint hemorrhage (HP:0005261) | 1.64762164 |
| 156 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.64226898 |
| 157 | Asymmetric septal hypertrophy (HP:0001670) | 1.64098176 |
| 158 | Elbow flexion contracture (HP:0002987) | 1.63185791 |
| 159 | Bone pain (HP:0002653) | 1.63037536 |
| 160 | Malnutrition (HP:0004395) | 1.62463498 |
| 161 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.62313185 |
| 162 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.61968366 |
| 163 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.61893003 |
| 164 | Abnormal platelet function (HP:0011869) | 1.61799187 |
| 165 | Impaired platelet aggregation (HP:0003540) | 1.61799187 |
| 166 | Menorrhagia (HP:0000132) | 1.61735192 |
| 167 | Glomerulonephritis (HP:0000099) | 1.60619948 |
| 168 | Chronic bronchitis (HP:0004469) | 1.60175809 |
| 169 | J-shaped sella turcica (HP:0002680) | 1.59955814 |
| 170 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.59909282 |
| 171 | Abnormal hand bone ossification (HP:0010660) | 1.59835267 |
| 172 | Absent frontal sinuses (HP:0002688) | 1.59644914 |
| 173 | Abnormality of skull ossification (HP:0002703) | 1.59297137 |
| 174 | Venous abnormality (HP:0002624) | 1.59254692 |
| 175 | Abnormal delivery (HP:0001787) | 1.59015750 |
| 176 | Abnormality of the thoracic spine (HP:0100711) | 1.58869201 |
| 177 | Advanced eruption of teeth (HP:0006288) | 1.58724758 |
| 178 | Natal tooth (HP:0000695) | 1.57647974 |
| 179 | Protuberant abdomen (HP:0001538) | 1.57530471 |
| 180 | Hyperglycinuria (HP:0003108) | 1.57401430 |
| 181 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.56891671 |
| 182 | Cupped ribs (HP:0000887) | 1.56674025 |
| 183 | Hemorrhage of the eye (HP:0011885) | 1.55880695 |
| 184 | Spinal cord compression (HP:0002176) | 1.55789795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.01537964 |
| 2 | TAOK3 | 4.76520109 |
| 3 | PASK | 3.19395926 |
| 4 | INSRR | 2.90192720 |
| 5 | PRPF4B | 2.84684327 |
| 6 | FLT3 | 2.58954476 |
| 7 | TRIB3 | 2.53845487 |
| 8 | IRAK3 | 2.50261547 |
| 9 | FRK | 2.47962529 |
| 10 | BCKDK | 2.09851594 |
| 11 | SMG1 | 2.06176740 |
| 12 | PKN2 | 2.02753001 |
| 13 | EEF2K | 1.96362548 |
| 14 | ICK | 1.96199325 |
| 15 | SCYL2 | 1.92305910 |
| 16 | LATS2 | 1.84072113 |
| 17 | MST1R | 1.83321031 |
| 18 | SIK1 | 1.77961658 |
| 19 | CDK12 | 1.77143497 |
| 20 | STK10 | 1.76125111 |
| 21 | MAP3K10 | 1.74557057 |
| 22 | BRSK2 | 1.73931173 |
| 23 | EIF2AK3 | 1.64708225 |
| 24 | PTK6 | 1.59041381 |
| 25 | LATS1 | 1.57110825 |
| 26 | KSR2 | 1.52694447 |
| 27 | ZAP70 | 1.50670911 |
| 28 | MAP3K13 | 1.48357852 |
| 29 | MAP2K3 | 1.40906229 |
| 30 | MAP3K2 | 1.40317915 |
| 31 | JAK3 | 1.38182541 |
| 32 | HIPK2 | 1.37662745 |
| 33 | LMTK2 | 1.35771745 |
| 34 | PRKD3 | 1.32159698 |
| 35 | MAP3K3 | 1.28697546 |
| 36 | EPHA2 | 1.28073343 |
| 37 | PDGFRA | 1.26851708 |
| 38 | AKT3 | 1.26697538 |
| 39 | IRAK4 | 1.23412358 |
| 40 | MAP3K1 | 1.20951701 |
| 41 | DDR2 | 1.17630863 |
| 42 | RPS6KA4 | 1.14856391 |
| 43 | LRRK2 | 1.13868816 |
| 44 | ARAF | 1.10682927 |
| 45 | PTK2 | 1.10643191 |
| 46 | TESK1 | 1.08608522 |
| 47 | NEK9 | 1.05786885 |
| 48 | MYLK | 0.98668968 |
| 49 | STK24 | 0.97725738 |
| 50 | RPS6KB2 | 0.96164742 |
| 51 | CDC42BPA | 0.95968898 |
| 52 | MET | 0.94924944 |
| 53 | PRKD2 | 0.94459737 |
| 54 | FGFR4 | 0.93076499 |
| 55 | MOS | 0.93049507 |
| 56 | STK38 | 0.90266323 |
| 57 | JAK2 | 0.90242061 |
| 58 | MTOR | 0.89141774 |
| 59 | MAP3K8 | 0.88730679 |
| 60 | RET | 0.88185379 |
| 61 | MAPKAPK3 | 0.86460966 |
| 62 | ACVR1B | 0.86341951 |
| 63 | PDK4 | 0.85953815 |
| 64 | PDK3 | 0.85953815 |
| 65 | PRKG2 | 0.84395005 |
| 66 | TRPM7 | 0.81066619 |
| 67 | IRAK1 | 0.80097859 |
| 68 | PDPK1 | 0.78540723 |
| 69 | TBK1 | 0.77344509 |
| 70 | DMPK | 0.75574841 |
| 71 | STK3 | 0.72461808 |
| 72 | BTK | 0.71777831 |
| 73 | MAP2K2 | 0.70757041 |
| 74 | MAPK11 | 0.70602320 |
| 75 | BMX | 0.70205708 |
| 76 | NTRK1 | 0.70132248 |
| 77 | MARK2 | 0.70120098 |
| 78 | CHUK | 0.69936411 |
| 79 | MAP3K9 | 0.69661525 |
| 80 | RPS6KA2 | 0.69064991 |
| 81 | YES1 | 0.69016847 |
| 82 | MAPK15 | 0.68839620 |
| 83 | RIPK1 | 0.68728477 |
| 84 | EPHB2 | 0.67667304 |
| 85 | NEK6 | 0.67577107 |
| 86 | PIM2 | 0.66979056 |
| 87 | CDK6 | 0.66759790 |
| 88 | CDK9 | 0.65374308 |
| 89 | EPHA3 | 0.63327070 |
| 90 | BMPR2 | 0.62733163 |
| 91 | KSR1 | 0.62382484 |
| 92 | PAK4 | 0.60051119 |
| 93 | CDC7 | 0.59631909 |
| 94 | TYRO3 | 0.59253876 |
| 95 | EIF2AK1 | 0.58969590 |
| 96 | TAOK2 | 0.58509325 |
| 97 | ITK | 0.57408373 |
| 98 | TTN | 0.56809695 |
| 99 | TGFBR2 | 0.56446114 |
| 100 | MAP3K5 | 0.55808121 |
| 101 | SGK3 | 0.55370291 |
| 102 | RIPK4 | 0.54414472 |
| 103 | ROCK2 | 0.54040650 |
| 104 | MAP3K11 | 0.53416624 |
| 105 | WEE1 | 0.53334864 |
| 106 | CSK | 0.53215350 |
| 107 | RAF1 | 0.52511040 |
| 108 | MST4 | 0.52292728 |
| 109 | PIM1 | 0.52035466 |
| 110 | TEC | 0.51607127 |
| 111 | FGFR3 | 0.50500050 |
| 112 | MAP3K7 | 0.48813015 |
| 113 | NEK2 | 0.48570458 |
| 114 | WNK4 | 0.47819358 |
| 115 | MARK3 | 0.47776332 |
| 116 | CDK4 | 0.46840644 |
| 117 | MAP2K1 | 0.46224184 |
| 118 | JAK1 | 0.45924366 |
| 119 | PRKCI | 0.45660546 |
| 120 | RPS6KB1 | 0.44707835 |
| 121 | ILK | 0.44492842 |
| 122 | GSK3A | 0.42897768 |
| 123 | ERBB4 | 0.42808108 |
| 124 | ALK | 0.41601598 |
| 125 | MAP3K14 | 0.41259906 |
| 126 | MAP3K6 | 0.41158025 |
| 127 | PIK3CG | 0.40452956 |
| 128 | STK38L | 0.40302803 |
| 129 | BRAF | 0.40284018 |
| 130 | MAPKAPK2 | 0.40135026 |
| 131 | PDK1 | 0.39997469 |
| 132 | SIK3 | 0.39953176 |
| 133 | EPHB1 | 0.39762169 |
| 134 | CLK1 | 0.38870958 |
| 135 | NME2 | 0.38048689 |
| 136 | TYK2 | 0.37383426 |
| 137 | RPS6KC1 | 0.37170486 |
| 138 | RPS6KL1 | 0.37170486 |
| 139 | MELK | 0.36986768 |
| 140 | FGR | 0.36943630 |
| 141 | PAK2 | 0.35604526 |
| 142 | PDGFRB | 0.35442759 |
| 143 | CDK7 | 0.35380701 |
| 144 | PDK2 | 0.34504501 |
| 145 | TGFBR1 | 0.33441838 |
| 146 | RPS6KA6 | 0.32882477 |
| 147 | MAP4K1 | 0.32316457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.59163098 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.58686974 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.93651931 |
| 4 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.87342439 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.66552863 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.60424275 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.89070746 |
| 8 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.76438004 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.72356211 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.71120797 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69634692 |
| 12 | Focal adhesion_Homo sapiens_hsa04510 | 1.69523121 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61932721 |
| 14 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.59446366 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.57734530 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.55243790 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51779896 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.51179956 |
| 19 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.51007351 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.50344318 |
| 21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.44200218 |
| 22 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.40328894 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38052547 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.36802228 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.30805028 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.30411100 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30332740 |
| 28 | Endometrial cancer_Homo sapiens_hsa05213 | 1.29729597 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29525528 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26852877 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25163336 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.23866694 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.23674062 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23637561 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23279242 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21395454 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18824610 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.17780594 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16988300 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13894836 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.13530666 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12782590 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 1.12348956 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07134887 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06515742 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.06497677 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05888747 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05773432 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04781555 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04542273 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.03613331 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02579433 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00094959 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99537443 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99298973 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98675569 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.97877270 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96358629 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.96073804 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94888905 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94793905 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93795822 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93610180 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.91883834 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90703066 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89162292 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89131127 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88754963 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.88395093 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87246409 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86484486 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.86245673 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85445890 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.83511686 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83272963 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.83071168 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82360906 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82119083 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.81597666 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81595455 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.80662416 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77879189 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77595825 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77549158 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77153509 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76338373 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74787528 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74061818 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73154321 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72154623 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71808125 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.71086657 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70846312 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70482467 |
| 95 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70199395 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70137120 |
| 97 | RNA transport_Homo sapiens_hsa03013 | 0.69752691 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69704052 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.69224880 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67603939 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66956202 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66110813 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66092447 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.65792478 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.64583283 |
| 106 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.64570996 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64493681 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64225804 |
| 109 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63959226 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63332695 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62824097 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.62096835 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.61389987 |
| 114 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61388342 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.60500600 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59576743 |
| 117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59125392 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.58998160 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57462771 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57459799 |
| 121 | Prostate cancer_Homo sapiens_hsa05215 | 0.57339038 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56877729 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.56838619 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56654146 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56543383 |
| 126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56462795 |
| 127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55136392 |
| 128 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54435826 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54098437 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53766447 |
| 131 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.53011749 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.52841097 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52362590 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.51024734 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50069662 |
| 136 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48615789 |
| 137 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47906881 |
| 138 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47043262 |
| 139 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46336134 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46299381 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46156718 |
| 142 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45527945 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44751487 |
| 144 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44251997 |
| 145 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43995866 |
| 146 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43426967 |
| 147 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43069401 |
| 148 | Insulin secretion_Homo sapiens_hsa04911 | 0.40233539 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40068876 |
| 150 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39839961 |
| 151 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39654626 |
| 152 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35791484 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35397987 |
| 154 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35274558 |
| 155 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33885791 |
| 156 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32491943 |
| 157 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31926197 |
| 158 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31057535 |
| 159 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30604220 |
| 160 | Adherens junction_Homo sapiens_hsa04520 | 0.28961434 |
| 161 | Amoebiasis_Homo sapiens_hsa05146 | 0.24243440 |
| 162 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.24084931 |
| 163 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24065766 |

